Picard Medical partners with Hydrix to develop next-gen artificial heart

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Picard Medical partners with Hydrix to develop next-gen artificial heart

SynCardia and Hydrix Enter into Development Collaboration to Advance the Emperor, SynCardia’s Next Generation Total Artificial Heart

January 12, 2026 8:30 AM EST

TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (Picard or the Company), parent company of SynCardia Systems LLC, maker of the worlds first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the Agreement) with Hydrix Services Pty Ltd (Hydrix), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardias next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a... More